Evidence map›Paper›PMID 32231314›Full record

ArticleNature biomedical engineering2020

Targeted tumour theranostics in mice via carbon quantum dots structurally mimicking large amino acids.

Shuhua Li, Wen Su, Hao Wu, Ting Yuan, Chang Yuan, Jun Liu, Gang Deng, Xingchun Gao, Zeming Chen, Youmei Bao and 13 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Nature biomedical engineering, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 108 papers.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed
19.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 394 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 3 institutions in 2 countries.

Shuhua Li *College of Chemistry, Key Laboratories of Theoretical and Computational Photochemistry, and Radiopharmaceuticals, Ministry of Education, Beijing Normal University, Beijing, China.
Wen Su *College of Chemistry, Key Laboratories of Theoretical and Computational Photochemistry, and Radiopharmaceuticals, Ministry of Education, Beijing Normal University, Beijing, China.ORCID http://orcid.org/0000-0002-5023-9445
Hao Wu *College of Chemistry, Key Laboratories of Theoretical and Computational Photochemistry, and Radiopharmaceuticals, Ministry of Education, Beijing Normal University, Beijing, China.ORCID http://orcid.org/0000-0002-2350-8865
Ting YuanCollege of Chemistry, Key Laboratories of Theoretical and Computational Photochemistry, and Radiopharmaceuticals, Ministry of Education, Beijing Normal University, Beijing, China.
Chang YuanCollege of Chemistry, Key Laboratories of Theoretical and Computational Photochemistry, and Radiopharmaceuticals, Ministry of Education, Beijing Normal University, Beijing, China.
Jun LiuDepartment of Neurosurgery, Yale University, New Haven, CT, USA.
Gang DengDepartment of Neurosurgery, Yale University, New Haven, CT, USA.
Xingchun GaoDepartment of Neurosurgery, Yale University, New Haven, CT, USA.
Zeming ChenDepartment of Neurosurgery, Yale University, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-4222-4945
Youmei BaoDepartment of Neurosurgery, Yale University, New Haven, CT, USA.
Fanglong YuanCollege of Chemistry, Key Laboratories of Theoretical and Computational Photochemistry, and Radiopharmaceuticals, Ministry of Education, Beijing Normal University, Beijing, China.
Shixin ZhouDepartment of Cell Biology and Stem Cell Research Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
Hongwei TanCollege of Chemistry, Key Laboratories of Theoretical and Computational Photochemistry, and Radiopharmaceuticals, Ministry of Education, Beijing Normal University, Beijing, China.
Yunchao LiCollege of Chemistry, Key Laboratories of Theoretical and Computational Photochemistry, and Radiopharmaceuticals, Ministry of Education, Beijing Normal University, Beijing, China.
Xiaohong LiCollege of Chemistry, Key Laboratories of Theoretical and Computational Photochemistry, and Radiopharmaceuticals, Ministry of Education, Beijing Normal University, Beijing, China.
Louzhen FanCollege of Chemistry, Key Laboratories of Theoretical and Computational Photochemistry, and Radiopharmaceuticals, Ministry of Education, Beijing Normal University, Beijing, China. lzfan@bnu.edu.cn.ORCID http://orcid.org/0000-0002-1319-5412
Jia ZhuCollege of Chemistry, Key Laboratories of Theoretical and Computational Photochemistry, and Radiopharmaceuticals, Ministry of Education, Beijing Normal University, Beijing, China. zhu.jia@bnu.edu.cn.ORCID http://orcid.org/0000-0002-4938-2850
Ann T ChenDepartment of Biomedical Engineering, Yale University, New Haven, CT, USA.
Fuyao LiuDepartment of Neurosurgery, Yale University, New Haven, CT, USA.
Yu ZhouDepartment of Neurosurgery, Yale University, New Haven, CT, USA.
Miao LiDepartment of Neurosurgery, Yale University, New Haven, CT, USA.
Xingchen ZhaiDepartment of Neurosurgery, Yale University, New Haven, CT, USA.
Jiangbing ZhouDepartment of Neurosurgery, Yale University, New Haven, CT, USA. jiangbing.zhou@yale.edu.ORCID http://orcid.org/0000-0002-1201-5360
Beijing Normal University · CNYale University · USPeking University · CN

Funding

Southern New England Partnership In Stroke Research, Innovation and Treatment (SPIRIT)U24NS107215 · NINDS · YALE UNIVERSITY · PI MARK Jay ALBERTS, Karen L Furie · 2018 to 2026
$3.0M
Improved glyburide therapy via acid- triggered release functional nanoparticles and therapeutic imagingR01NS110721 · NINDS · YALE UNIVERSITY · PI SHETH, KEVIN NAVIN, ZHOU, JIANGBING · 2019 to 2023
$1.9M
Systemic gene therapy for glioblastomaR01NS095817 · NINDS · YALE UNIVERSITY · PI ZHOU, JIANGBING · 2016 to 2020
$1.8M
NINDS NIH HHS R01 NS095817NINDS NIH HHS R01 NS110721NINDS NIH HHS U24 NS107215
6 · The paper itself

Abstract

Strategies for selectively imaging and delivering drugs to tumours typically leverage differentially upregulated surface molecules on cancer cells. Here, we show that intravenously injected carbon quantum dots, functionalized with multiple paired α-carboxyl and amino groups that bind to the large neutral amino acid transporter 1 (which is expressed in most tumours), selectively accumulate in human tumour xenografts in mice and in an orthotopic mouse model of human glioma. The functionalized quantum dots, which structurally mimic large amino acids and can be loaded with aromatic drugs through π-π stacking interactions, enabled-in the absence of detectable toxicity-near-infrared fluorescence and photoacoustic imaging of the tumours and a reduction in tumour burden after the targeted delivery of chemotherapeutics to the tumours. The versatility of functionalization and high tumour selectivity of the quantum dots make them broadly suitable for tumour-specific imaging and drug delivery.

Indexed as

Amino AcidsAnimalsBiomedical EngineeringBrain NeoplasmsCarbonCell Line, TumorDrug Delivery SystemsFemaleHumansMiceMice, Inbred BALB CMice, NudeQuantum DotsTheranostic NanomedicineAmino AcidsCarbon

Identifiers

PMID32231314
PMCPMC7197249
OpenAlexW3013150558

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.